GlycoMimetics Appoints Seasoned Business Development Executive Armand Girard as New Vice President, Corporate Development
"We are pleased to have Armand join the
"It's very exciting to join
About
This press release contains forward-looking statements regarding
GlycoMimetics' planned activities with respect to the clinical
development of rivipansel and other matters. Actual results may differ
materially from those in these forward-looking statements. For a further
description of the risks associated with these statements, as well as
other risks facing
bhahn@glycomimetics.com
Source:
News Provided by Acquire Media